Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small cell lung cancer, head and neck squamous cell carcinoma, and cervical cancer; and ITIL-306 to recognize folate receptor alpha (FOLR1) with indications, including gynecological, non-small cell lung cancer, renal caner, and others. The company was incorporated in 2018 and is headquartered in Dallas, Texas.

Explore Instil Bio, Inc. (TIL) trends on wallstreetbets, highlighting its potential as a next meme stock. Check if TIL ranks among the best meme stocks today, signaling its status as a top meme stock to watch. Also, review any recent trades of TIL by notable politicians, like Nancy Pelosi, to gauge its prominence in the meme stock conversation.

Instil Bio, Inc.

💎🤲 Meme Status

🚀 Quote

🏛️ Trades by Politicians